Showing 741-750 of 9116 results for "".
Chemical Peels for Lip Augmentation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/chemical-peels-for-lip-augmentation--dcwokite/19585/For patients looking for natural results or who want an alternative to hyaluronic acid fillers and needles, deep chemical peels are an excellent alternative for lip augmentation, explains Kachiu Lee, MD. She shares treatment pearls and discusses the kind of results patients can expect.Beyond SPF: Protecting the Skin
https://practicaldermatology.com/topics/skin-cancer-photoprotection/beyond-spf-protecting-the-skin-/18535/In addition to protecting the skin from sun damage, it's becoming increasingly important to consider pollution's role in skin aging. Arianne Shadi Kourosh, MD, and Rebecca Kazin, MD discuss the need for a well tailored regimen and what to look for in sun protection, barrier protection, cleaners, anImplementing Skincare Solutions in Practice
https://practicaldermatology.com/topics/practice-management/implementing-skincare-solutions-in-practice/18902/Leslie Baumann, MD, FAAD discusses the challenges of offering effective skincare recommendations to patients and shares some of the practical solutions she has implemented in her practice. The author of "The Skin Type Solution," describes how she chooses skincare for each individual patient and giveSEO Playbook: On-Page Factors
https://practicaldermatology.com/topics/practice-management/seo-playbook-on-page-factors/18994/Internet marketing is constantly changing--especially when it comes to SEO. Learn how on-page factors like Content, HTML, and architecture affect SEO and the marketing value of your practice website.Levia Patient Testimonial with Lauren
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/levia-patient-testimonial-with-lauren/19427/Lauren discusses her experiences with psoriasis and Levia. Levia®, from Lerner Medical, provides Personal Targeted Phototherapy® for the self-treatment of psoriasis in the privacy and convenience of a patient's home. Levia incorporates easy to use software for physician control of dosimetry and inclLevia Patient Testimonial with Irene
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/levia-patient-testimonial-with-irene/19426/Irene discusses her experiences with psoriasis and Levia. Levia®, from Lerner Medical, provides Personal Targeted Phototherapy® for the self-treatment of psoriasis in the privacy and convenience of a patient's home. Levia incorporates easy to use software for physician control of dosimetry and incluThe Neuroimmune Mechanisms Driving Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37136/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, discusses the neuroimmune mechanisms that drive prurigo nodularis and how they differ from those in chronic pruritus and atopicThe First 5 Minutes with a Patient
https://practicaldermatology.com/series/pa-perspectives/first-5-minutes-patient/27105/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses the importance of crafting the right message during the first 5 minutes with a patient.The Emergence of Targeted Therapies for Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/the-emergence-of-targeted-therapies-for-prurigo-nodularis/48775/Christopher Bunick, MD, FAAD, discusses the importance of acknowledging prurigo nodularis as a distinct disease with its own molecular and transcriptomic features distinguishing it from atopic dermatitis, and how targeting the IL-31 receptor can change the game.Therapeutic Approaches in Pediatric Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37158/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, explains how to adjust a therapeutic approach to pediatric atopic dermatitis, particularly when considering long-term use of topical steroids or calcin